F. Hoffmann-La Roche AG are a Swiss multinational healthcare company. They operate worldwide under two separate divisions. Both Pharmaceuticals, and Diagnostics. Its holding company, Roche Holding AG, has bearer shares listed on the SIX Swiss Exchange. The company headquarters are located in Basel, Switzerland.
Roche have been committed to improving lives since the company was founded in 1896 in Basel, Switzerland. Today, Roche creates innovative medicines and diagnostic tests that help millions of patients globally.
The founder was Fritz Hoffmann-La Roche. He was a top pioneering entrepreneur of his time. Fritz was convinced that the future belonged to branded pharmaceutical products.
For over 120 years Roche has been committed to improving lives. The long-term thinking of our founders has allowed us to stay true to this vision. Our greatest contribution to society is lasting innovation. When acting sustainably, we also aim to provide a rewarding workplace, be a trustworthy partner and engage in the communities we work in and with.
The frontrunner in personalised healthcare
This was one of the first companies to bring targeted treatments to patients. With combined strength in pharmaceuticals and diagnostics, they are better equipped than any other company to further drive personalised healthcare. Two-thirds of their Research and Development projects are being developed with companion diagnostics.
The world’s largest biotech company
Roche are the world’s number 1 in biotech with 17 biopharmaceuticals on the market. Over half of the compounds in their product pipeline are biopharmaceuticals, enabling them to deliver better-targeted therapies.
The global leader in cancer treatments
Roche have been at the forefront of cancer research and treatment for over 50 years. They have medicines for breast, skin, colon, ovarian, lung and numerous other cancers.
The leading provider of in vitro diagnostics
They offer doctors profound information to guide treatments. As well as the fact they answer more patients’ questions than any other company. And their tests enable hospitals and labs to deliver that information quickly and reliably.
1896: The founding year – first successes
F. Hoffmann-La Roche & Co. was founded at a time when the face of Europe was being changed by industrial revolution. On October 1, 1896, at the age of 28, Fritz Hoffmann-La Roche launched his company. It was the successor company to Hoffmann, Traub & Co in Basel, Switzerland.
Roche was among the first to recognise a change was coming. He knew that the industrial manufacture of medicines would be a major advance in the fight against disease. Since then, Roche has grown into one of the world’s leading healthcare companies.
Pharmacist Carl Schaerges, who was the first head of research, together with chemist Emil C. Barell demonstrate the presense of Iodine in thyroid extracts. This results in Roche’s first patent and scientific publications. The launch of Aiodin marks the earliest in a series of thyroid preparations by Roche.
Clonazepam belongs to a group of medicines called benzodiazepines. It is used for the treatment of epilepsy in infants, children and adults. It is the active pharmaceutical ingredient used in the Roche product Rivotril.